VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Purchased by Stifel Financial Corp

Stifel Financial Corp boosted its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 46.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,401 shares of the company’s stock after acquiring an additional 3,591 shares during the period. Stifel Financial Corp’s holdings in VanEck Pharmaceutical ETF were worth $984,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. SBI Securities Co. Ltd. purchased a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at about $29,000. Activest Wealth Management acquired a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $32,000. Tidemark LLC raised its position in shares of VanEck Pharmaceutical ETF by 123.6% during the 4th quarter. Tidemark LLC now owns 1,183 shares of the company’s stock valued at $102,000 after buying an additional 654 shares during the period. OLD Mission Capital LLC acquired a new position in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $224,000. Finally, Grimes & Company Inc. acquired a new position in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $310,000.

VanEck Pharmaceutical ETF Stock Down 0.9 %

PPH stock opened at $84.96 on Friday. VanEck Pharmaceutical ETF has a 52-week low of $77.67 and a 52-week high of $99.51. The stock has a market cap of $610.86 million, a price-to-earnings ratio of 24.60 and a beta of 0.72. The business has a fifty day moving average of $87.93 and a two-hundred day moving average of $88.63.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Tuesday, April 1st were issued a $0.5245 dividend. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $2.10 annualized dividend and a yield of 2.47%. The ex-dividend date of this dividend was Tuesday, April 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.